{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T22:12:48Z","timestamp":1793225568420,"version":"4.5.0"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T00:00:00Z","timestamp":1756166400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T00:00:00Z","timestamp":1756166400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFC3400700"],"award-info":[{"award-number":["2022YFC3400700"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Shanghai Municipal Science and Technology Major Project","award":["2023SHZDZX02"],"award-info":[{"award-number":["2023SHZDZX02"]}]},{"name":"Grant of Shanghai Municipal Health Commission","award":["2022JC012"],"award-info":[{"award-number":["2022JC012"]}]},{"DOI":"10.13039\/501100012247","name":"Program of Shanghai Academic Research Leader","doi-asserted-by":"publisher","award":["22XD1423300"],"award-info":[{"award-number":["22XD1423300"]}],"id":[{"id":"10.13039\/501100012247","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Shanghai Oriental Youth Elite Talents Program","award":["QNZH2024009"],"award-info":[{"award-number":["QNZH2024009"]}]},{"DOI":"10.13039\/501100013285","name":"Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013285","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"DOI":"10.1186\/s12916-025-04329-y","type":"journal-article","created":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T13:29:07Z","timestamp":1756214947000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["The causal effects of remnant cholesterol on increased risk of cardiovascular diseases in East Asians"],"prefix":"10.1186","volume":"23","author":[{"given":"Chenhao","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haolong","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengyao","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingxia","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinran","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer Ming Jen","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingfeng","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiru","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sijia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxiang","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo-Chong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,26]]},"reference":[{"issue":"1","key":"4329_CR1","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.cell.2015.01.036","volume":"161","author":"JL Goldstein","year":"2015","unstructured":"Goldstein JL, Brown MS. A century of cholesterol and coronaries: from plaques to genes to statins. Cell. 2015;161(1):161\u201372.","journal-title":"Cell"},{"issue":"10","key":"4329_CR2","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1038\/s41569-024-01039-5","volume":"21","author":"BA Ference","year":"2024","unstructured":"Ference BA, Braunwald E, Catapano AL. The LDL cumulative exposure hypothesis: evidence and practical applications. Nat Rev Cardiol. 2024;21(10):701\u201316.","journal-title":"Nat Rev Cardiol"},{"issue":"32","key":"4329_CR3","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.1093\/eurheartj\/ehx144","volume":"38","author":"BA Ference","year":"2017","unstructured":"Ference BA, Ginsberg HN, Graham I, Ray KK, Packard CJ, Bruckert E, Hegele RA, Krauss RM, Raal FJ, Schunkert H, et al. Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel. Eur Heart J. 2017;38(32):2459\u201372.","journal-title":"Eur Heart J"},{"issue":"21","key":"4329_CR4","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1056\/NEJMoa0706628","volume":"357","author":"PJ Barter","year":"2007","unstructured":"Barter PJ, Caulfield M, Eriksson M, Grundy SM, Kastelein JJ, Komajda M, Lopez-Sendon J, Mosca L, Tardif JC, Waters DD, et al. Effects of torcetrapib in patients at high risk for coronary events. N Engl J Med. 2007;357(21):2109\u201322.","journal-title":"N Engl J Med"},{"issue":"20","key":"4329_CR5","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1056\/NEJMoa1609581","volume":"376","author":"AM Lincoff","year":"2017","unstructured":"Lincoff AM, Nicholls SJ, Riesmeyer JS, Barter PJ, Brewer HB, Fox KAA, Gibson CM, Granger C, Menon V, Montalescot G, et al. Evacetrapib and cardiovascular outcomes in high-risk vascular disease. N Engl J Med. 2017;376(20):1933\u201342.","journal-title":"N Engl J Med"},{"key":"4329_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2020.00088","volume":"7","author":"DS Dhindsa","year":"2020","unstructured":"Dhindsa DS, Sandesara PB, Shapiro MD, Wong ND. The evolving understanding and approach to residual cardiovascular risk management. Front Cardiovasc Med. 2020;7: 88.","journal-title":"Front Cardiovasc Med"},{"issue":"11","key":"4329_CR7","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1093\/eurheartj\/ehr112","volume":"32","author":"MJ Chapman","year":"2011","unstructured":"Chapman MJ, Ginsberg HN, Amarenco P, Andreotti F, Boren J, Catapano AL, Descamps OS, Fisher E, Kovanen PT, Kuivenhoven JA, et al. Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management. Eur Heart J. 2011;32(11):1345\u201361.","journal-title":"Eur Heart J"},{"issue":"9","key":"4329_CR8","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/s41569-022-00676-y","volume":"19","author":"J Boren","year":"2022","unstructured":"Boren J, Taskinen MR, Bjornson E, Packard CJ. Metabolism of triglyceride-rich lipoproteins in health and dyslipidaemia. Nat Rev Cardiol. 2022;19(9):577\u201392.","journal-title":"Nat Rev Cardiol"},{"issue":"4","key":"4329_CR9","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1161\/CIRCRESAHA.115.306249","volume":"118","author":"BG Nordestgaard","year":"2016","unstructured":"Nordestgaard BG. Triglyceride-rich lipoproteins and atherosclerotic cardiovascular disease: new insights from epidemiology, genetics, and biology. Circ Res. 2016;118(4):547\u201363.","journal-title":"Circ Res"},{"issue":"4","key":"4329_CR10","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.jacc.2012.08.1026","volume":"61","author":"A Varbo","year":"2013","unstructured":"Varbo A, Benn M, Tybjaerg-Hansen A, Jorgensen AB, Frikke-Schmidt R, Nordestgaard BG. Remnant cholesterol as a causal risk factor for ischemic heart disease. J Am Coll Cardiol. 2013;61(4):427\u201336.","journal-title":"J Am Coll Cardiol"},{"issue":"34","key":"4329_CR11","doi-asserted-by":"publisher","first-page":"3258","DOI":"10.1093\/eurheartj\/ehab705","volume":"43","author":"BN Wadstrom","year":"2022","unstructured":"Wadstrom BN, Wulff AB, Pedersen KM, Jensen GB, Nordestgaard BG. Elevated remnant cholesterol increases the risk of peripheral artery disease, myocardial infarction, and ischaemic stroke: a cohort-based study. Eur Heart J. 2022;43(34):3258\u201369.","journal-title":"Eur Heart J"},{"issue":"42","key":"4329_CR12","doi-asserted-by":"publisher","first-page":"4324","DOI":"10.1093\/eurheartj\/ehab432","volume":"42","author":"R Quispe","year":"2021","unstructured":"Quispe R, Martin SS, Michos ED, Lamba I, Blumenthal RS, Saeed A, Lima J, Puri R, Nomura S, Tsai M, et al. Remnant cholesterol predicts cardiovascular disease beyond LDL and ApoB: a primary prevention study. Eur Heart J. 2021;42(42):4324\u201332.","journal-title":"Eur Heart J"},{"issue":"4","key":"4329_CR13","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/nrcardio.2010.223","volume":"8","author":"BJ Arsenault","year":"2011","unstructured":"Arsenault BJ, Boekholdt SM, Kastelein JJ. Lipid parameters for measuring risk of cardiovascular disease. Nat Rev Cardiol. 2011;8(4):197\u2013206.","journal-title":"Nat Rev Cardiol"},{"issue":"9","key":"4329_CR14","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1093\/eurheartj\/eht571","volume":"36","author":"MV Holmes","year":"2015","unstructured":"Holmes MV, Asselbergs FW, Palmer TM, Drenos F, Lanktree MB, Nelson CP, Dale CE, Padmanabhan S, Finan C, Swerdlow DI, et al. Mendelian randomization of blood lipids for coronary heart disease. Eur Heart J. 2015;36(9):539\u201350.","journal-title":"Eur Heart J"},{"issue":"1","key":"4329_CR15","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1001\/jamacardio.2023.4115","volume":"9","author":"MG Levin","year":"2024","unstructured":"Levin MG, Burgess S. Mendelian randomization as a tool for cardiovascular research: a review. JAMA Cardiol. 2024;9(1):79\u201389.","journal-title":"JAMA Cardiol"},{"issue":"1","key":"4329_CR16","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1186\/s12933-023-01927-z","volume":"22","author":"B Guan","year":"2023","unstructured":"Guan B, Wang A, Xu H. Causal associations of remnant cholesterol with cardiometabolic diseases and risk factors: a mendelian randomization analysis. Cardiovasc Diabetol. 2023;22(1):207.","journal-title":"Cardiovasc Diabetol"},{"issue":"9","key":"4329_CR17","doi-asserted-by":"publisher","first-page":"e373","DOI":"10.1161\/ATVBAHA.123.319297","volume":"43","author":"EP Navarese","year":"2023","unstructured":"Navarese EP, Vine D, Proctor S, Grzelakowska K, Berti S, Kubica J, Raggi P. Independent causal effect of remnant cholesterol on atherosclerotic cardiovascular outcomes: a Mendelian randomization study. Arterioscler Thromb Vasc Biol. 2023;43(9):e373\u201380.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"4329_CR18","doi-asserted-by":"publisher","first-page":"2451","DOI":"10.1038\/s41467-024-46686-x","volume":"15","author":"Y Zhao","year":"2024","unstructured":"Zhao Y, Zhuang Z, Li Y, Xiao W, Song Z, Huang N, Wang W, Dong X, Jia J, Clarke R, et al. Elevated blood remnant cholesterol and triglycerides are causally related to the risks of cardiometabolic multimorbidity. Nat Commun. 2024;15(1):2451.","journal-title":"Nat Commun"},{"issue":"10","key":"4329_CR19","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1038\/s41588-021-00931-x","volume":"53","author":"S Sakaue","year":"2021","unstructured":"Sakaue S, Kanai M, Tanigawa Y, Karjalainen J, Kurki M, Koshiba S, Narita A, Konuma T, Yamamoto K, Akiyama M, et al. A cross-population atlas of genetic associations for 220 human phenotypes. Nat Genet. 2021;53(10):1415\u201324.","journal-title":"Nat Genet"},{"issue":"7944","key":"4329_CR20","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1038\/s41586-022-05473-8","volume":"613","author":"MI Kurki","year":"2023","unstructured":"Kurki MI, Karjalainen J, Palta P, Sipila TP, Kristiansson K, Donner KM, Reeve MP, Laivuori H, Aavikko M, Kaunisto MA, et al. Finngen provides genetic insights from a well-phenotyped isolated population. Nature. 2023;613(7944):508\u201318.","journal-title":"Nature"},{"issue":"12","key":"4329_CR21","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1007\/s10654-010-9525-6","volume":"25","author":"X Gao","year":"2010","unstructured":"Gao X, Hofman A, Hu Y, Lin H, Zhu C, Jeekel J, Jin X, Wang J, Gao J, Yin Y, et al. The Shanghai Changfeng study: a community-based prospective cohort study of chronic diseases among middle-aged and elderly: objectives and design. Eur J Epidemiol. 2010;25(12):885\u201393.","journal-title":"Eur J Epidemiol"},{"issue":"4","key":"4329_CR22","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1007\/s43657-021-00021-2","volume":"1","author":"Q Wu","year":"2021","unstructured":"Wu Q, Huang QX, Zeng HL, Ma S, Lin HD, Xia MF, Tang HR, Gao X. Prediction of metabolic disorders using NMR-based metabolomics: the Shanghai Changfeng study. Phenomics. 2021;1(4):186\u201398.","journal-title":"Phenomics"},{"key":"4329_CR23","doi-asserted-by":"crossref","unstructured":"Huang Q, Qadri SF, Bian H, Yi X, Lin C, Yang X, Zhu X, Lin H, Yan H, Chang X et al: A metabolome-derived score predicts metabolic dysfunction-associated steatohepatitis and mortality from liver disease. J Hepatol 2024.","DOI":"10.1016\/j.jhep.2024.10.015"},{"issue":"4","key":"4329_CR24","first-page":"1064","volume":"45","author":"Z Liu","year":"2016","unstructured":"Liu Z, Wang Y, Zhang Y, Chu X, Wang Z, Qian D, Chen F, Xu J, Li S, Jin L, et al. Cohort profile: the Rugao Longevity and Ageing Study (RuLAS). Int J Epidemiol. 2016;45(4):1064\u201373.","journal-title":"Int J Epidemiol"},{"key":"4329_CR25","doi-asserted-by":"crossref","unstructured":"Wang F, Luo Q, Chen Y, Liu Y, Xu K, Adhikari K, Cai X, Liu J, Li Y, Liu X et al: A genome-wide scan on individual typology angle found variants at SLC24A2 associated with skin color variation in Chinese populations. J Invest Dermatol 2022, 142(4):1223\u20131227 e1214.","DOI":"10.1016\/j.jid.2021.07.186"},{"issue":"1","key":"4329_CR26","doi-asserted-by":"publisher","first-page":"65","DOI":"10.4103\/2470-7511.312594","volume":"6","author":"S Shalaimaiti","year":"2021","unstructured":"Shalaimaiti S, Dai Y-X, Wu H-Y, Qian J-Y, Zheng Y, Yao K, Ge J-B. Clinical and genetic characteristics of coronary artery disease in Chinese young adults: rationale and design of the prospectivegenetic characteristics of coronaryartery disease in ChiNese young aDults (GRAND) Study. Cardiology Plus. 2021;6(1):65\u201373.","journal-title":"Cardiology Plus"},{"issue":"24","key":"4329_CR27","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.124.036906","volume":"13","author":"Z Mei","year":"2024","unstructured":"Mei Z, Xu L, Huang Q, Lin C, Yu M, Shali S, Wu H, Lu Y, Wu R, Wang Z, et al. Metabonomic biomarkers of plaque burden and instability in patients with coronary atherosclerotic disease after moderate lipid-lowering therapy. J Am Heart Assoc. 2024;13(24): e036906.","journal-title":"J Am Heart Assoc"},{"issue":"7726","key":"4329_CR28","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/s41586-018-0579-z","volume":"562","author":"C Bycroft","year":"2018","unstructured":"Bycroft C, Freeman C, Petkova D, Band G, Elliott LT, Sharp K, Motyer A, Vukcevic D, Delaneau O, O\u2019Connell J, et al. The UK biobank resource with deep phenotyping and genomic data. Nature. 2018;562(7726):203\u20139.","journal-title":"Nature"},{"issue":"1","key":"4329_CR29","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1038\/s41467-023-36231-7","volume":"14","author":"H Julkunen","year":"2023","unstructured":"Julkunen H, Cichonska A, Tiainen M, Koskela H, Nybo K, Makela V, Nokso-Koivisto J, Kristiansson K, Perola M, Salomaa V, et al. Atlas of plasma NMR biomarkers for health and disease in 118,461 individuals from the UK Biobank. Nat Commun. 2023;14(1):604.","journal-title":"Nat Commun"},{"issue":"20","key":"4329_CR30","doi-asserted-by":"publisher","first-page":"11962","DOI":"10.1021\/acs.analchem.8b02412","volume":"90","author":"B Jimenez","year":"2018","unstructured":"Jimenez B, Holmes E, Heude C, Tolson RF, Harvey N, Lodge SL, Chetwynd AJ, Cannet C, Fang F, Pearce JTM, et al. Quantitative lipoprotein subclass and low molecular weight metabolite analysis in human serum and plasma by (1)H NMR spectroscopy in a multilaboratory trial. Anal Chem. 2018;90(20):11962\u201371.","journal-title":"Anal Chem"},{"key":"4329_CR31","doi-asserted-by":"crossref","unstructured":"Huang Q, Chen Q, Yi X, Wang H, Wang Q, Zhi H, Wu J, Wang DW, Tang H: Reproducibility of NMR-based quantitative metabolomics and HBV-caused changes in human serum lipoprotein subclasses and small metabolites. Journal of Pharmaceutical Analysis 2024:101180.","DOI":"10.1016\/j.jpha.2024.101180"},{"issue":"7890","key":"4329_CR32","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/s41586-021-04064-3","volume":"600","author":"SE Graham","year":"2021","unstructured":"Graham SE, Clarke SL, Wu KH, Kanoni S, Zajac GJM, Ramdas S, Surakka I, Ntalla I, Vedantam S, Winkler TW, et al. The power of genetic diversity in genome-wide association studies of lipids. Nature. 2021;600(7890):675\u20139.","journal-title":"Nature"},{"issue":"3","key":"4329_CR33","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1038\/ng.3190","volume":"47","author":"PR Loh","year":"2015","unstructured":"Loh PR, Tucker G, Bulik-Sullivan BK, Vilhjalmsson BJ, Finucane HK, Salem RM, Chasman DI, Ridker PM, Neale BM, Berger B, et al. Efficient bayesian mixed-model analysis increases association power in large cohorts. Nat Genet. 2015;47(3):284\u201390.","journal-title":"Nat Genet"},{"issue":"17","key":"4329_CR34","doi-asserted-by":"publisher","first-page":"2190","DOI":"10.1093\/bioinformatics\/btq340","volume":"26","author":"CJ Willer","year":"2010","unstructured":"Willer CJ, Li Y, Abecasis GR. METAL: fast and efficient meta-analysis of genomewide association scans. Bioinformatics. 2010;26(17):2190\u20131.","journal-title":"Bioinformatics"},{"key":"4329_CR35","doi-asserted-by":"crossref","unstructured":"Chang CC, Chow CC, Tellier LC, Vattikuti S, Purcell SM, Lee JJ. Second-generation PLINK: rising to the challenge of larger and richer datasets. Gigascience. 2015;4.","DOI":"10.1186\/s13742-015-0047-8"},{"key":"4329_CR36","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.k601","volume":"362","author":"NM Davies","year":"2018","unstructured":"Davies NM, Holmes MV, Davey Smith G. Reading Mendelian randomisation studies: a guide, glossary, and checklist for clinicians. BMJ. 2018;362: k601.","journal-title":"BMJ"},{"issue":"3","key":"4329_CR37","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1093\/ije\/dyq151","volume":"40","author":"BL Pierce","year":"2011","unstructured":"Pierce BL, Ahsan H, Vanderweele TJ. Power and instrument strength requirements for Mendelian randomization studies using multiple genetic variants. Int J Epidemiol. 2011;40(3):740\u201352.","journal-title":"Int J Epidemiol"},{"issue":"4","key":"4329_CR38","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1002\/jrsm.1346","volume":"10","author":"J Bowden","year":"2019","unstructured":"Bowden J, Holmes MV. Meta-analysis and Mendelian randomization: a review. Res Synth Methods. 2019;10(4):486\u201396.","journal-title":"Res Synth Methods"},{"issue":"16","key":"4329_CR39","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1001\/jama.2021.18236","volume":"326","author":"VW Skrivankova","year":"2021","unstructured":"Skrivankova VW, Richmond RC, Woolf BAR, Yarmolinsky J, Davies NM, Swanson SA, VanderWeele TJ, Higgins JPT, Timpson NJ, Dimou N, et al. Strengthening the reporting of observational studies in epidemiology using mendelian randomization: the STROBE-MR statement. JAMA. 2021;326(16):1614\u201321.","journal-title":"JAMA"},{"key":"4329_CR40","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n2233","volume":"375","author":"VW Skrivankova","year":"2021","unstructured":"Skrivankova VW, Richmond RC, Woolf BAR, Davies NM, Swanson SA, VanderWeele TJ, Timpson NJ, Higgins JPT, Dimou N, Langenberg C, et al. Strengthening the reporting of observational studies in epidemiology using mendelian randomisation (STROBE-MR): explanation and elaboration. BMJ. 2021;375: n2233.","journal-title":"BMJ"},{"issue":"1","key":"4329_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s43586-021-00092-5","volume":"2","author":"E Sanderson","year":"2022","unstructured":"Sanderson E, Glymour MM, Holmes MV, Kang H, Morrison J, Munaf\u00f2 MR, Palmer T, Schooling CM, Wallace C, Zhao Q, et al. Mendelian randomization. Nat Rev Methods Primers. 2022;2(1): 6.","journal-title":"Nat Rev Methods Primers"},{"issue":"1","key":"4329_CR42","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1161\/CIRCULATIONAHA.124.068885","volume":"150","author":"D De Oliveira-Gomes","year":"2024","unstructured":"De Oliveira-Gomes D, Joshi PH, Peterson ED, Rohatgi A, Khera A, Navar AM. Apolipoprotein B: bridging the gap between evidence and clinical practice. Circulation. 2024;150(1):62\u201379.","journal-title":"Circulation"},{"issue":"3","key":"4329_CR43","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1093\/ije\/dyy262","volume":"48","author":"E Sanderson","year":"2019","unstructured":"Sanderson E, Davey Smith G, Windmeijer F, Bowden J. An examination of multivariable Mendelian randomization in the single-sample and two-sample summary data settings. Int J Epidemiol. 2019;48(3):713\u201327.","journal-title":"Int J Epidemiol"},{"issue":"1","key":"4329_CR44","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s13073-017-0414-4","volume":"9","author":"R Nagy","year":"2017","unstructured":"Nagy R, Boutin TS, Marten J, Huffman JE, Kerr SM, Campbell A, Evenden L, Gibson J, Amador C, Howard DM, et al. Exploration of haplotype research consortium imputation for genome-wide association studies in 20,032 Generation Scotland participants. Genome Med. 2017;9(1):23.","journal-title":"Genome Med"},{"issue":"2","key":"4329_CR45","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/s41588-020-00757-z","volume":"53","author":"N Sinnott-Armstrong","year":"2021","unstructured":"Sinnott-Armstrong N, Tanigawa Y, Amar D, Mars N, Benner C, Aguirre M, Venkataraman GR, Wainberg M, Ollila HM, Kiiskinen T, et al. Genetics of 35 blood and urine biomarkers in the UK Biobank. Nat Genet. 2021;53(2):185\u201394.","journal-title":"Nat Genet"},{"issue":"11","key":"4329_CR46","doi-asserted-by":"publisher","first-page":"2264","DOI":"10.1161\/ATVBAHA.109.201020","volume":"30","author":"DM Waterworth","year":"2010","unstructured":"Waterworth DM, Ricketts SL, Song K, Chen L, Zhao JH, Ripatti S, Aulchenko YS, Zhang W, Yuan X, Lim N, et al. Genetic variants influencing circulating lipid levels and risk of coronary artery disease. Arterioscler Thromb Vasc Biol. 2010;30(11):2264\u201376.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"7307","key":"4329_CR47","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1038\/nature09270","volume":"466","author":"TM Teslovich","year":"2010","unstructured":"Teslovich TM, Musunuru K, Smith AV, Edmondson AC, Stylianou IM, Koseki M, Pirruccello JP, Ripatti S, Chasman DI, Willer CJ, et al. Biological, clinical and population relevance of 95 loci for blood lipids. Nature. 2010;466(7307):707\u201313.","journal-title":"Nature"},{"issue":"3","key":"4329_CR48","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003062","volume":"17","author":"TG Richardson","year":"2020","unstructured":"Richardson TG, Sanderson E, Palmer TM, Ala-Korpela M, Ference BA, Davey Smith G, Holmes MV. Evaluating the relationship between circulating lipoprotein lipids and apolipoproteins with risk of coronary heart disease: a multivariable mendelian randomisation analysis. PLoS Med. 2020;17(3): e1003062.","journal-title":"PLoS Med"},{"issue":"8006","key":"4329_CR49","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1038\/s41586-024-07148-y","volume":"628","author":"MK Karjalainen","year":"2024","unstructured":"Karjalainen MK, Karthikeyan S, Oliver-Williams C, Sliz E, Allara E, Fung WT, Surendran P, Zhang W, Jousilahti P, Kristiansson K, et al. Genome-wide characterization of circulating metabolic biomarkers. Nature. 2024;628(8006):130\u20138.","journal-title":"Nature"},{"issue":"10","key":"4329_CR50","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1038\/ng.939","volume":"43","author":"YJ Kim","year":"2011","unstructured":"Kim YJ, Go MJ, Hu C, Hong CB, Kim YK, Lee JY, Hwang JY, Oh JH, Kim DJ, Kim NH, et al. Large-scale genome-wide association studies in East Asians identify new genetic loci influencing metabolic traits. Nat Genet. 2011;43(10):990\u20135.","journal-title":"Nat Genet"},{"issue":"1","key":"4329_CR51","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/s41467-019-13770-6","volume":"11","author":"FA Hagenbeek","year":"2020","unstructured":"Hagenbeek FA, Pool R, van Dongen J, Draisma HHM, Jan Hottenga J, Willemsen G, Abdellaoui A, Fedko IO, den Braber A, Visser PJ, et al. Heritability estimates for 361 blood metabolites across 40 genome-wide association studies. Nat Commun. 2020;11(1):39.","journal-title":"Nat Commun"},{"issue":"11","key":"4329_CR52","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1093\/eurjpc\/zwad036","volume":"30","author":"SJ Lee","year":"2023","unstructured":"Lee SJ, Kim S-E, Go T-H, Kang DR, Jeon H-S, Kim Y-I, Cho D-H, Park YJ, Lee J-H, Lee J-W, et al. Remnant cholesterol, low-density lipoprotein cholesterol, and incident cardiovascular disease among Koreans: a national population-based study. Eur J Prev Cardiol. 2023;30(11):1142\u201350.","journal-title":"Eur J Prev Cardiol"},{"issue":"23","key":"4329_CR53","doi-asserted-by":"publisher","first-page":"2736","DOI":"10.1016\/j.jacc.2020.10.029","volume":"76","author":"JR Burnett","year":"2020","unstructured":"Burnett JR, Hooper AJ, Hegele RA. Remnant cholesterol and atherosclerotic cardiovascular disease risk. J Am Coll Cardiol. 2020;76(23):2736\u20139.","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"4329_CR54","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1016\/j.bbalip.2011.09.021","volume":"1821","author":"EA Schwartz","year":"2012","unstructured":"Schwartz EA, Reaven PD. Lipolysis of triglyceride-rich lipoproteins, vascular inflammation, and atherosclerosis. Biochim Biophys Acta. 2012;1821(5):858\u201366.","journal-title":"Biochim Biophys Acta"},{"issue":"6","key":"4329_CR55","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1161\/ATVBAHA.110.206573","volume":"30","author":"J Golledge","year":"2010","unstructured":"Golledge J, Norman PE. Atherosclerosis and abdominal aortic aneurysm: cause, response, or common risk factors? Arterioscler Thromb Vasc Biol. 2010;30(6):1075\u20137.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"4","key":"4329_CR56","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/s41569-018-0114-9","volume":"16","author":"J Golledge","year":"2019","unstructured":"Golledge J. Abdominal aortic aneurysm: update on pathogenesis and medical treatments. Nat Rev Cardiol. 2019;16(4):225\u201342.","journal-title":"Nat Rev Cardiol"},{"issue":"1","key":"4329_CR57","doi-asserted-by":"publisher","first-page":"5652","DOI":"10.1038\/s41467-024-49921-7","volume":"15","author":"S Zheng","year":"2024","unstructured":"Zheng S, Tsao PS, Pan C. Abdominal aortic aneurysm and cardiometabolic traits share strong genetic susceptibility to lipid metabolism and inflammation. Nat Commun. 2024;15(1):5652.","journal-title":"Nat Commun"},{"key":"4329_CR58","unstructured":"Taddei C, Zhou B, Bixby H, Carrillo-Larco RM, Danaei G, Jackson R, Farzadfar F, Sophiea MK, Di Cesare M, Iurilli MLC et al: Repositioning of the global epicentre of non-optimal cholesterol. Nature 2020, 582(7810):73."},{"issue":"6","key":"4329_CR59","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1097\/SLA.0000000000005716","volume":"277","author":"P Song","year":"2023","unstructured":"Song P, He Y, Adeloye D, Zhu Y, Ye X, Yi Q, Rahimi K, Rudan I, Global Health Epidemiology Research G. The global and regional prevalence of abdominal aortic aneurysms: a systematic review and modeling analysis. Ann Surg. 2023;277(6):912\u20139.","journal-title":"Ann Surg"},{"key":"4329_CR60","volume":"49","author":"RSJ Goh","year":"2024","unstructured":"Goh RSJ, Chong B, Jayabaskaran J, Jauhari SM, Chan SP, Kueh MTW, Shankar K, Li H, Chin YH, Kong G, et al. The burden of cardiovascular disease in Asia from 2025 to 2050: a forecast analysis for East Asia, South Asia, South-East Asia, Central Asia, and high-income Asia Pacific regions. Lancet Reg Health. 2024;49: 101138.","journal-title":"Lancet Reg Health"},{"issue":"2","key":"4329_CR61","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1161\/CIRCRESAHA.117.306458","volume":"121","author":"A Bhatnagar","year":"2017","unstructured":"Bhatnagar A. Environmental determinants of cardiovascular disease. Circ Res. 2017;121(2):162\u201380.","journal-title":"Circ Res"},{"key":"4329_CR62","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpc.2022.100342","volume":"10","author":"HE Bays","year":"2022","unstructured":"Bays HE, Kulkarni A, German C, Satish P, Iluyomade A, Dudum R, Thakkar A, Rifai MA, Mehta A, Thobani A, et al. Ten things to know about ten cardiovascular disease risk factors - 2022. Am J Prev Cardiol. 2022;10: 100342.","journal-title":"Am J Prev Cardiol"},{"issue":"16","key":"4329_CR63","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1093\/eurheartj\/ehac783","volume":"44","author":"PE Sturzebecher","year":"2023","unstructured":"Sturzebecher PE, Katzmann JL, Laufs U. What is \u2018remnant cholesterol\u2019? Eur Heart J. 2023;44(16):1446\u20138.","journal-title":"Eur Heart J"},{"key":"4329_CR64","unstructured":"Biobank Japan access results. Available from: https:\/\/pheweb.jp\/. Cited 2025 January 2"},{"key":"4329_CR65","unstructured":"FinnGen access results. Available from: https:\/\/www.finngen.fi\/en\/access_results. Cited 2025 January 2"}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-025-04329-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12916-025-04329-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-025-04329-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T18:24:13Z","timestamp":1757442253000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedicine.biomedcentral.com\/articles\/10.1186\/s12916-025-04329-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,26]]},"references-count":65,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4329"],"URL":"https:\/\/doi.org\/10.1186\/s12916-025-04329-y","relation":{},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,26]]},"assertion":[{"value":"17 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The National Survey of Physical Traits is the subproject of the National Science & Technology Basic Research Project which was approved by the Ethics Committee of Human Genetic Resources of the School of Life Sciences, Fudan University (14117). The Shanghai Changfeng study was approved by the Ethical Committee of Zhongshan Hospital, Fudan University (2013\u2013132). The Rugao Longevity and Aging study was approved by the Human Ethics Committee of the School of Life Sciences, Fudan University (BE1815). The GRAND study was approved by the central Ethics Committee at Zhongshan Hospital, Fudan University (B2017-051). All participants or their legal representatives provided informed consent before joining the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have consent for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"495"}}